Shares were up after the company announced higher-than-expected second quarter earnings last week. Mr. Ellis also said the market for spinal implants and cardiac rhythm management devices might be stabilizing.
Related Articles on Supply Chain:
Commentary: Pharmaceutical Companies More Careful About Off-Label Promotion
GE Unveils Discovery IGS 730 Interventional Imaging System at RSNA
Medtronic Sales High Despite Challenges for Heart and Spine Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.